Cys-TAT (47-57) - 1 mg
- Cat.Number : AS-61212
- Manufacturer Ref. :
-
Availability :
In stock
Alternative choices
This is a TAT peptide with Cysteine at the N-terminus. This peptide corresponds to the protein transduction domain of the TAT protein. In some studies this has been used as a PKCε inhibitor peptide and also conjugated to PKC peptides and other molecules such as antisense oligomers for examining cell penetrating abilities.
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
Molecular Formula |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
Downloads
You may also be interested in the following product(s)
Citations
Single molecule sensitive multivalent polyethylene glycol probes for RNA imaging.
Bioconj Chem . 2010 Feb 08 ; 21(3) 483 | DOI : 10.1021/bc9003876.
- A. Lifland
Peptides derived from the C2 domain of protein kinase C epsilon (epsilon PKC) modulate epsilon PKC activity and identify potential protein-protein interaction surfaces.
J Biol Chem . 2006 Dec 02 ; 282 4113 | DOI : 10.1074/jbc.M608521200.
- R. Brandman
References
ɛPKC confers acute tolerance to cerebral ischemic reperfusion injury
Neurosci lett. . 2008 Aug 15 ; 441(1) 120 | DOI : https://doi.org/10.1016/j.neulet.2008.05.080
- R. Bright
- et al
Cellular Uptake of Antisense Morpholino Oligomers Conjugated to Arginine-Rich Peptides
Bioconj Chem. . 2004 Feb 28 ; 15(2) 290 | DOI : 10.1021/bc034221g
- HM. Moultin
- et al